Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedMay 26, 2022
DataAggregated Company Financials
Companies26
  • 7D2.3%
  • 3M18.8%
  • 1Y27.4%
  • YTD15.7%

In the last week, the Pharma industry is up 2.3%, with AstraZeneca up 0.8%. This means that the industry has gained 27% over the past year. As for the next few years, earnings are expected to grow by 21% per annum.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sat, 28 May 2022UKĀ£266.7bUKĀ£73.6bUKĀ£4.6b17x
Mon, 25 Apr 2022UKĀ£262.3bUKĀ£67.2bUKĀ£4.8b20.1x
Wed, 23 Mar 2022UKĀ£246.4bUKĀ£66.4bUKĀ£4.7b27.1x
Fri, 18 Feb 2022UKĀ£234.4bUKĀ£65.3bUKĀ£4.7b31.3x
Sun, 16 Jan 2022UKĀ£232.2bUKĀ£61.0bUKĀ£5.6b30.7x
Tue, 14 Dec 2021UKĀ£227.2bUKĀ£61.9bUKĀ£5.7b31.2x
Thu, 11 Nov 2021UKĀ£245.0bUKĀ£59.2bUKĀ£7.5b25.7x
Sat, 09 Oct 2021UKĀ£227.7bUKĀ£58.4bUKĀ£7.5b27.8x
Mon, 06 Sep 2021UKĀ£230.1bUKĀ£58.1bUKĀ£7.5b30.3x
Wed, 04 Aug 2021UKĀ£221.3bUKĀ£58.1bUKĀ£7.5b26.7x
Sat, 08 May 2021UKĀ£185.5bUKĀ£56.2bUKĀ£8.5b25.4x
Tue, 09 Feb 2021UKĀ£182.2bUKĀ£57.2bUKĀ£8.3b25.7x
Mon, 02 Nov 2020UKĀ£182.0bUKĀ£57.9bUKĀ£8.4b40.9x
Thu, 06 Aug 2020UKĀ£201.9bUKĀ£59.5bUKĀ£8.5b44.3x
Sun, 10 May 2020UKĀ£205.0bUKĀ£59.1bUKĀ£6.8b22.2x
Sat, 01 Feb 2020UKĀ£197.9bUKĀ£55.7bUKĀ£6.0b18.7x
Tue, 05 Nov 2019UKĀ£197.6bUKĀ£56.4bUKĀ£6.6b17.9x
Fri, 09 Aug 2019UKĀ£104.5bUKĀ£21.8bUKĀ£2.1b34x
Median PE Ratio

33.5x


Total Market Cap: UKĀ£163.6bTotal Earnings: UKĀ£6.1bTotal Revenue: UKĀ£52.0bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Pharma Industry Median PE3Y Average 28.4x202020212022
Current Industry PE
  • Investors are more pessimistic on the industry, indicating that they anticipate long-term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 17.0x which is lower than its 3-year average PE of 28.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 9.0% per year over the last three years.
  • Meanwhile revenues for these companies have grown 12% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does U.K. Pharma compare with similar industries?

GB Market1.04%
Healthcare2.17%
Pharma2.26%
Pharma2.26%
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AZN AstraZenecaUKĀ£105.800.8%
+UKĀ£1.3b
31.5%PS5x
DPH Dechra PharmaceuticalsUKĀ£36.104.6%
+UKĀ£173.4m
-12.3%PS53.7x
INDV IndiviorUKĀ£3.222.5%
+UKĀ£53.3m
106.0%PS17.2x
POLB Poolbeg PharmaUKĀ£0.06955.7%
+UKĀ£12.3m
n/an/a
FUM Futura MedicalUKĀ£0.3010.4%
+UKĀ£8.2m
-34.1%PB9x
Simply Wall Stā„¢
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GSK

UKĀ£17.33

GSK

7D

-1.7%

1Y

28.9%